PROCEPT BioRobotics (PRCT) Net Income Growth (3y) (2023 - 2026)

PROCEPT BioRobotics (PRCT) Net Income Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Abbott Laboratories 183.20 Bn 175.91 Bn 6.27 Bn -6.51%
2 Stryker 128.87 Bn 125.99 Bn 3.81 Bn 7.96%
3 Medtronic 108.88 Bn 99.66 Bn 6.41 Bn 1.93%
4 Boston Scientific 68.33 Bn 66.87 Bn 3.61 Bn 62.29%
5 Edwards Lifesciences 47.31 Bn 43.64 Bn 1.29 Bn -
6 Dexcom 28.65 Bn 27.53 Bn 750.30 Mn 60.12%
7 GE HealthCare Technologies 28.40 Bn 26.11 Bn 1.98 Bn 2.38%
8 Smith & Nephew 26.97 Bn 26.40 Bn - -
9 Koninklijke Philips 25.55 Bn 22.42 Bn 2.07 Bn 280.49%
10 PROCEPT BioRobotics 993.46 Mn 747.82 Mn 53.95 Mn 25.96%

Historic Data

Download Data
DateValue
Mar 31, 2026 25.96%
Dec 31, 2025 -10.84%
Sep 30, 2025 -15.39%
Jun 30, 2025 -46.57%
Mar 31, 2025 -8.00%
Dec 31, 2024 -4.19%
Sep 30, 2024 -25.02%
Jun 30, 2024 -29.32%
Mar 31, 2024 -48.03%
Dec 31, 2023 -30.88%
Sep 30, 2023 -34.42%